Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+6.44%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$20.1B
AUM Growth
+$466M
(+2.4%)
Cap. Flow
-$382M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
16.11%
Holding
1,209
New
301
Increased
255
Reduced
241
Closed
292
Top Buys
| 1 |
Salesforce
CRM
|
$394M |
| 2 |
Amazon
AMZN
|
$236M |
| 3 |
Analog Devices
ADI
|
$130M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$105M |
| 5 |
SMAR
Smartsheet Inc.
SMAR
|
$100M |
Top Sells
| 1 |
Applied Materials
AMAT
|
$253M |
| 2 |
DXC Technology
DXC
|
$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$191M |
| 4 |
NXP Semiconductors
NXPI
|
$158M |
| 5 |
Baidu
BIDU
|
$157M |
Sector Composition
| 1 | Technology | 27.26% |
| 2 | Healthcare | 21.86% |
| 3 | Consumer Discretionary | 13.95% |
| 4 | Financials | 8.05% |
| 5 | Communication Services | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Relmada Therapeutics
RLMD
$54.4M
| $6.23M | 0.03% |
194,510
+22,010
| +13% | +$705K |
|
527
Alto Ingredients
ALTO
$89M
| $6.2M | 0.03% |
+1,014,686
| New | +$6.2M |
|
528
Replimune Group
REPL
$472M
| $6.2M | 0.03% |
161,300
-453,978
| -74% | -$17.4M |
|
529
OrthoPediatrics
KIDS
$519M
| $6.2M | 0.03% |
98,075
+57,541
| +142% | +$3.64M |
|
530
Royal Caribbean
RCL
$95.5B
| $6.14M | 0.03% |
71,988
-161,871
| -69% | -$13.8M |
|
531
Option Care Health
OPCH
$4.75B
| $6.12M | 0.03% |
+280,000
| New | +$6.12M |
|
532
Revolution Medicines
RVMD
$7.68B
| $6.11M | 0.03% |
+192,600
| New | +$6.11M |
|
|
DCPH
533
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.08M | 0.03% |
+166,100
| New | +$6.08M |
|
|
AZRE
534
DELISTED
Azure Power Global Limited
AZRE
| $6.05M | 0.03% |
224,867
+113,667
| +102% | +$3.06M |
|
535
Haemonetics
HAE
$2.6B
| $6.04M | 0.03% |
90,600
-99,100
| -52% | -$6.6M |
|
536
Carrier Global
CARR
$55.7B
| $6.02M | 0.03% |
123,900
-7,257
| -6% | -$353K |
|
537
Bloomin' Brands
BLMN
$589M
| $6.01M | 0.03% |
+221,446
| New | +$6.01M |
|
|
NBSE
538
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $5.99M | 0.03% |
+62,500
| New | +$5.99M |
|
539
ARS Pharmaceuticals
SPRY
$1.06B
| $5.96M | 0.03% |
192,996
-94,604
| -33% | -$2.92M |
|
540
Intuit
INTU
$188B
| $5.94M | 0.03% |
12,110
-32,590
| -73% | -$16M |
|
541
Colgate-Palmolive
CL
$68B
| $5.91M | 0.03% |
+72,694
| New | +$5.91M |
|
542
Weibo
WB
$2.83B
| $5.91M | 0.03% |
+112,400
| New | +$5.91M |
|
|
GNCA
543
DELISTED
Genocea Biosciences, Inc.
GNCA
| $5.85M | 0.03% |
+2,500,000
| New | +$5.85M |
|
544
Fulcrum Therapeutics
FULC
$395M
| $5.79M | 0.03% |
552,885
-22,361
| -4% | -$234K |
|
545
Outset Medical
OM
$245M
| $5.67M | 0.03% |
+7,560
| New | +$5.67M |
|
546
GCM Grosvenor
GCMG
$679M
| $5.65M | 0.03% |
542,100
+202,100
| +59% | +$2.11M |
|
547
EQT Corp
EQT
$31.6B
| $5.63M | 0.03% |
+252,677
| New | +$5.63M |
|
|
CMPS
548
Compass Pathways
CMPS
$482M
| $5.61M | 0.03% |
+147,000
| New | +$5.61M |
|
549
MACOM Technology Solutions
MTSI
$9.68B
| $5.58M | 0.03% |
87,000
+15,000
| +21% | +$961K |
|
550
Dillards
DDS
$8.99B
| $5.52M | 0.02% |
30,500
+10,100
| +50% | +$1.83M |
|